Cargando…
Identification of novel targets for antiangiogenic therapy by comparing the gene expressions of tumor and normal endothelial cells
Targeting tumor angiogenesis is an established strategy for cancer therapy. Because angiogenesis is not limited to pathological conditions such as cancer, molecular markers that can distinguish between physiological and pathological angiogenesis are required to develop more effective and safer appro...
Autores principales: | Otsubo, Tsuguteru, Hida, Yasuhiro, Ohga, Noritaka, Sato, Hideshi, Kai, Toshihiro, Matsuki, Yasushi, Takasu, Hideo, Akiyama, Kosuke, Maishi, Nako, Kawamoto, Taisuke, Shinohara, Nobuo, Nonomura, Katsuya, Hida, Kyoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BlackWell Publishing Ltd
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4317838/ https://www.ncbi.nlm.nih.gov/pubmed/24602018 http://dx.doi.org/10.1111/cas.12394 |
Ejemplares similares
-
Suprabasin as a novel tumor endothelial cell marker
por: Alam, Mohammad T, et al.
Publicado: (2014) -
Identification of Tumor Endothelial Cells with High Aldehyde Dehydrogenase Activity and a Highly Angiogenic Phenotype
por: Ohmura-Kakutani, Hitomi, et al.
Publicado: (2014) -
Hypoxia-Induced Reactive Oxygen Species Cause Chromosomal Abnormalities in Endothelial Cells in the Tumor Microenvironment
por: Kondoh, Miyako, et al.
Publicado: (2013) -
Tumor-Derived Microvesicles Induce Proangiogenic Phenotype in Endothelial Cells via Endocytosis
por: Kawamoto, Taisuke, et al.
Publicado: (2012) -
Tumor endothelial cells with high aldehyde dehydrogenase activity show drug resistance
por: Hida, Kyoko, et al.
Publicado: (2017)